Published in Am J Pathol on September 01, 1988
Micronodular thymic neoplasms: case series and literature review with emphasis on the spectrum of differentiation. Mod Pathol (2015) 0.80
Langerhans cells proliferation in ectopic micronodular thymoma with lymphoid stroma: a case report. Int J Clin Exp Pathol (2014) 0.78
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol (1982) 3.47
Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol (1985) 2.70
A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol (1981) 2.52
Intrathymic and extrathymic T cell maturation. Immunol Rev (1978) 2.47
Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol (1978) 2.22
Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol (1980) 2.16
Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J Immunol (1983) 2.13
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. Proc Natl Acad Sci U S A (1979) 2.07
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
The human thymic microenvironment. Adv Immunol (1984) 1.45
Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med (1984) 1.40
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Ontogeny of the human thymus during fetal development. J Clin Immunol (1987) 1.26
Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma. J Invest Dermatol (1982) 1.24
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. J Immunol (1983) 1.24
The human thymic microenvironment: cortical thymic epithelium is an antigenically distinct region of the thymic microenvironment. J Immunol (1984) 1.21
Pathology of thymic epithelial tumors. Curr Top Pathol (1986) 1.19
Immunohistochemical localization and distribution of S-100 proteins in the human lymphoreticular system. Am J Pathol (1984) 1.15
Thymic hormone-containing cells VI. Immunohistologic evidence for the simultaneous presence of thymulin, thymopoietin and thymosin alpha 1 in normal and pathological human thymuses. Eur J Immunol (1984) 1.06
Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus. Hum Pathol (1984) 1.06
Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities. Hum Pathol (1984) 1.06
Detection by S-100 immunolabelling of interdigitating reticulum cells in human thymomas. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 1.05
The human thymic microenvironment: thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation. Differentiation (1986) 1.04
Histiocytosis X. Hum Pathol (1983) 1.02
The role of the thymic microenvironment in promotion of early stages of human T cell maturation. Clin Res (1986) 1.02
Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. J Neuroimmunol (1986) 0.97
T-zone histiocytes with S100 protein. Development and distribution in human fetuses. Acta Pathol Jpn (1983) 0.96
Immunohistology of human thymomas. Arch Pathol Lab Med (1985) 0.95
The human thymic microenvironment. Phenotypic characterization of Hassall's bodies with the use of monoclonal antibodies. J Immunol (1985) 0.93
Characterization of human thymic dendritic cells in culture. Immunology (1986) 0.92
Immunohistochemical analysis of thymoma. Evidence for medullary origin of epithelial cells. Am J Surg Pathol (1984) 0.88
Human medullary thymocyte p80 antigen and In(Lu)-related p80 antigen reside on the same protein. Hum Immunol (1986) 0.85
Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions. Am J Pathol (1985) 0.84
Cortical thymocyte differentiation in thymomas: an immunohistologic analysis of the pathologic microenvironment. J Immunol (1987) 0.84
Histiocytosis X of the thymus in association with myasthenia gravis. Am J Clin Pathol (1986) 0.83
Epithelial nature of spindle-cell thymoma. An ultrastructural study. Cancer (1972) 0.83
Histiocytosis X (Langerhans' cell granulomatosis) of the thymus. A clinicopathologic study of four childhood cases. Am J Surg Pathol (1985) 0.82
The thymic microenvironment. Characterization of in vitro differentiation of the IT26R21 rat thymic epithelial cell line. Differentiation (1987) 0.82
Thymic changes in histiocytosis. Am J Clin Pathol (1982) 0.82
Heterogeneity of epithelial cells and reactive components in thymomas: an ultrastructural and immunohistochemical study. Ultrastruct Pathol (1986) 0.81
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci U S A (1988) 7.74
A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity (1996) 5.64
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med (1994) 5.03
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunol Today (1989) 2.96
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med (1995) 2.33
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol (1981) 2.30
The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med (1977) 2.26
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) (1980) 2.26
Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med (1999) 2.25
Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes. J Immunol (1977) 2.24
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer (1993) 2.21
Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and LFA-3 antigens. J Immunol (1987) 2.11
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. Proc Natl Acad Sci U S A (1979) 2.07
Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol (1989) 1.93
Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med (1982) 1.89
Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med (1979) 1.87
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol (1990) 1.78
Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J Immunol (1980) 1.75
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. J Exp Med (1981) 1.66
Human T lymphocyte antigens as defined by monoclonal antibodies. Immunol Rev (1981) 1.65
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol (1989) 1.63
Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol (2000) 1.55
Lipid metabolism in the newborn heart. J Clin Invest (1965) 1.55
Population studies of pepsinogen polymorphism. Am J Hum Genet (1973) 1.50
The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest (1978) 1.49
Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum (1989) 1.47
Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J Exp Med (1995) 1.47
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
The human thymic microenvironment. Adv Immunol (1984) 1.45
Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol (1989) 1.45
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci U S A (1990) 1.43
Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today (1989) 1.41
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol (1988) 1.40
Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med (1984) 1.40
Analysis of the human thymic perivascular space during aging. J Clin Invest (1999) 1.36
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36
Human T cell antigen expression by primate T cells. Science (1982) 1.35
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Activation of human B lymphocytes. X. Heterogeneity of concanavalin A-generated suppressor cells of the pokeweed mitogen-induced plaque-forming cell response of human peripheral blood lymphocytes. J Immunol (1978) 1.35
T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant (2001) 1.33
Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med (2000) 1.31
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol (1979) 1.29
Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J Clin Invest (1983) 1.29
Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J Immunol (2001) 1.28
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia (2012) 1.26
Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest (1983) 1.26
Ontogeny of the human thymus during fetal development. J Clin Immunol (1987) 1.26
Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood (1982) 1.25
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
In vitro growth and phenotypic characterization of mesodermal-derived and epithelial components of normal and abnormal human thymus. Hum Immunol (1985) 1.25
Human T cell antigen expression during the early stages of fetal thymic maturation. J Immunol (1985) 1.25
Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma. J Invest Dermatol (1982) 1.24
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. J Immunol (1983) 1.24
Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals. Cell Immunol (1978) 1.23
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. Mucosal Immunol (2013) 1.23
Mechanisms of corticosteroid action on lymphocyte subpopulations. IV. Effects of in vitro hydrocortisone on naturally occuring and mitogen-induced suppressor cells in man. Cell Immunol (1979) 1.23
Human thymic epithelial cells function as accessory cells for autologous mature thymocyte activation. J Immunol (1987) 1.21
The human thymic microenvironment: cortical thymic epithelium is an antigenically distinct region of the thymic microenvironment. J Immunol (1984) 1.21
Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. J Immunol (1993) 1.19
Removal of fibroblasts from human epithelial cell cultures with use of a complement fixing monoclonal antibody reactive with human fibroblasts and monocytes/macrophages. J Invest Dermatol (1989) 1.19
Defective lipid metabolism in the failing heart. J Clin Invest (1968) 1.19
Human thymic epithelial cells produce interleukin 1. J Immunol (1987) 1.19
Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells. Proc Natl Acad Sci U S A (1989) 1.17
Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J Immunol (1993) 1.17
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood (1989) 1.16
Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Proc Natl Acad Sci U S A (1991) 1.16
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia (2009) 1.15
Activation of human B lymphocytes. V. Kinetics and mechanisms of suppression of plaque-forming cell responses by concanavalin A-generated suppressor cells. J Immunol (1978) 1.15
Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol (1990) 1.15
Thymocyte LFA-1 and thymic epithelial cell ICAM-1 molecules mediate binding of activated human thymocytes to thymic epithelial cells. J Immunol (1990) 1.14
Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol (1992) 1.13
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst (1993) 1.12
CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today (1997) 1.10
Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med (1990) 1.10
A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor. J Immunol (1991) 1.09